The National Cancer Institute (NCI) is offering this grant to support investigator-initiated early phase (Phase 0, I, and II) clinical trials for cancer treatment and diagnosis. This grant is specifically for research projects focused on developing and testing cancer-targeted diagnostic and therapeutic interventions, aligning with the NCI’s DCTD and OHAM research missions. Proposed projects must involve at least one clinical trial pertinent to the scientific interests of specific NCI programs, including Cancer Therapy Evaluation, Imaging, Diagnosis, Radiation Research, Complementary and Alternative Medicine, and HIV and AIDS Malignancies Research. Applicants have the flexibility to propose an early phase trial independently or in combination with other relevant research aims, fostering critical advancements in oncology.
Opportunity ID: 357075
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-25-081 |
| Funding Opportunity Title: | National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 12, 2024 |
| Last Updated Date: | Nov 12, 2024 |
| Original Closing Date for Applications: | Jan 07, 2027 |
| Current Closing Date for Applications: | Jan 07, 2027 |
| Archive Date: | Feb 12, 2027 |
| Estimated Total Program Funding: | $499,999 |
| Award Ceiling: | $499,999 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) City or township governments County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public housing authorities/Indian housing authorities Independent school districts Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Special district governments Private institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-081.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357075 Full Announcement-PAR-25-081 -> PAR-25-081-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288692 | Jan 05, 2025 | Jan 07, 2027 | View |
Package 1
Mandatory forms
357075 RR_SF424_5_0-5.0.pdf
357075 PHS398_CoverPageSupplement_5_0-5.0.pdf
357075 RR_OtherProjectInfo_1_4-1.4.pdf
357075 PerformanceSite_4_0-4.0.pdf
357075 RR_KeyPersonExpanded_4_0-4.0.pdf
357075 PHS398_ResearchPlan_5_0-5.0.pdf
357075 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357075 RR_Budget_3_0-3.0.pdf
357075 RR_SubawardBudget30_3_0-3.0.pdf
357075 PHS398_ModularBudget_1_2-1.2.pdf
357075 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
